PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors ; volume:7 ; number:1 ; day:14 ; month:8 ; year:2019 ; pages:1-14 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (14.8.2019), 1-14, 12.2019
- Creator
-
Beyrend, Guillaume
van der Gracht, Esmé
Yilmaz, Ayse
van Duikeren, Suzanne
Camps, Marcel
Höllt, Thomas
Vilanova, Anna
van Unen, Vincent
Koning, Frits
de Miranda, Noel F. C. C.
Arens, Ramon
Ossendorp, Ferry
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0700-3
- URN
-
urn:nbn:de:101:1-2020010100551170993949
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Beyrend, Guillaume
- van der Gracht, Esmé
- Yilmaz, Ayse
- van Duikeren, Suzanne
- Camps, Marcel
- Höllt, Thomas
- Vilanova, Anna
- van Unen, Vincent
- Koning, Frits
- de Miranda, Noel F. C. C.
- Arens, Ramon
- Ossendorp, Ferry
- SpringerLink (Online service)
Other Objects (12)
Tumor-Infiltrating Lymphocytes in Wilms Tumor
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Relevance of tumor-infiltrating lymphocytes in breast cancer
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer
LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma
Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
Epigenetic quantification of tumor-infiltrating T-lymphocytes in epithelial ovarian tumors
Tumor-Infiltrating Lymphocytes in Wilms Tumor
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Relevance of tumor-infiltrating lymphocytes in breast cancer
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer
LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma
Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
Epigenetic quantification of tumor-infiltrating T-lymphocytes in epithelial ovarian tumors
Tumor-Infiltrating Lymphocytes in Wilms Tumor
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Relevance of tumor-infiltrating lymphocytes in breast cancer
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer
LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma
Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients